December 24, 2024 - 15:35

Experts warn that the expiration of Affordable Care Act (ACA) subsidies could significantly deter potential entrepreneurs in Oklahoma. Without access to affordable health care options, many individuals may think twice before launching their own businesses. The uncertainty surrounding health care costs can create a daunting barrier for those considering entrepreneurship, as they weigh the risks associated with both starting a new venture and securing health insurance.
Oklahoma has seen a surge in small business innovations over recent years, driven by a robust entrepreneurial spirit. However, the potential loss of ACA subsidies poses a serious threat to this growth. Many aspiring business owners rely on these subsidies to ensure that they can afford necessary health care while pursuing their dreams. If these financial supports are removed, the fear of high medical expenses could lead to a decline in new business formation.
In a state where small businesses are vital to the economy, the implications of losing these subsidies could resonate far beyond individual entrepreneurs, affecting job creation and economic stability statewide.
June 27, 2026 - 07:59
Gilbert Chamber Foundation brings AI basics to local businessesBusiness owners in Gilbert and the East Valley are getting a hands-on look at how artificial intelligence could keep them competitive. The Gilbert Chamber Foundation has introduced a new initiative...
June 26, 2026 - 18:02
Meet ‘Pepper’ Baumer, The Man With Hot Sauce In His BloodHot sauce has become one of the fastest-growing sectors in the food industry, and few people understand that heat better than `Pepper` Baumer. As the third-generation owner of Crystal, a...
June 26, 2026 - 11:50
‘Disgusting and vile’: Locals react to arrest of Tampa business owner on AI child porn chargesA Tampa business owner is behind bars this week, facing more than 100 felony charges after authorities say he used artificial intelligence to create child pornography. Local residents and fellow...
June 25, 2026 - 20:17
Investigational heart drug for nonobstructive HCM one step closer to FDA approvalAn experimental oral medication for a specific type of hypertrophic cardiomyopathy is advancing toward potential U.S. approval. The drug, known as ninerafaxstat, is being developed for patients...